N-[[2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-3-oxo-1H-pyrazol-5-yl]methyl]pyridine-3-sulfonamide
C24H21FN6O3S — CID 146568881
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-3-oxo-1H-pyrazol-5-yl]methyl]pyridine-3-sulfonamide
N-[[2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-3-oxo-1H-pyrazol-5-yl]methyl]pyridine-3-sulfonamide (PubChem CID 146568881) has the molecular formula C24H21FN6O3S and a molecular weight of 492.54 g/mol. Its IUPAC name is N-[[2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-3-oxo-1H-pyrazol-5-yl]methyl]pyridine-3-sulfonamide.
Molecular Properties
| Compound Name | N-[[2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-3-oxo-1H-pyrazol-5-yl]methyl]pyridine-3-sulfonamide |
|---|---|
| PubChem CID | 146568881 |
| Molecular Formula | C24H21FN6O3S |
| Molecular Weight | 492.54 g/mol |
| Exact Mass | 492.14 |
| IUPAC Name | N-[[2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-3-oxo-1H-pyrazol-5-yl]methyl]pyridine-3-sulfonamide |
| SMILES | O=c1c(CCc2ccc(F)cc2)c(CNS(=O)(=O)c2cccnc2)[nH]n1-c1nc2ccccc2[nH]1 |
| InChI | InChI=1S/C24H21FN6O3S/c25-17-10-7-16(8-11-17)9-12-19-22(15-27-35(33,34)18-4-3-13-26-14-18)30-31(23(19)32)24-28-20-5-1-2-6-21(20)29-24/h1-8,10-11,13-14,27,30H,9,12,15H2,(H,28,29) |
| InChIKey | RTOBVYAAXKSDGH-UHFFFAOYSA-N |
| XLogP | 2.84 |
| TPSA | 125.53 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 492.54 |
| LogP ≤ 5 | 2.84 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146568881 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.